Bipolar Disorder Market

Bipolar Disorder Market Size by Drug Class (Mood Stabilizers, Antipsychotic Drugs, Antianxiety Drugs, Anticonvulsants, Antidepressant Drugs and Others), Mechanism of Action (Selective Serotonin Reuptake Inhibitors, Tricyclic Antidepressants, Benzodiazepines, Serotonin Norepinephrine Reuptake Inhibitors, Monoamine Oxidase, Beta Blockers and Others), Global Industry Analysis, Share, Growth, Trends, and Forecast 2022 to 2030

Base Year: 2021 Historical Data: 2019-20
  • Report ID: TBI-13033
  • Published Date: Nov, 2022
  • Pages: 235
  • Category: Healthcare
  • Format: PDF
Buy @ $4700.00 Request Sample PDF

The global bipolar disorder market is expected to grow from USD 5.11 billion in 2022 to USD 6.05 billion by 2030, at a CAGR of 2.15% during the forecast period 2022-2030. The increasing awareness about bipolar disorder facilitated by government initiatives would drive the global bipolar disorder market.

Market Introduction:

Bipolar disorder is a medical condition associated with extreme mood swings. Bipolar disorder was formerly called manic depression. The mental condition is associated with two forms of mental state, one which is called hypomania and the other called depression. A person suffering from bipolar disorder rotates between these states of emotional highs and emotional lows their entire life. Emotional highs are associated with a hyperactive lifestyle, full of energy, euphoric mood, enthusiasm, happiness and joyous mood. On the other hand, emotional lows are associated with low energy, low motivation, emptiness, hopelessness, and loss of interest in life. Extreme emotional triggers include suicidal thoughts. The duration of such episodes is unknown. The exact causes of bipolar disorder are also not defined. Genetics and different brain chemistry are considered significant factors that may cause bipolar disorder. The surrounding environment may also trigger the condition. Bipolar disorder is a chronic condition and does not have a cure as of yet. Medications and psychotherapy control the episodes that disrupt the lives of millions every day. The symptoms are wide-ranging and are listed under broad categories: mood, cognitive ability, weight, behavioural changes and sleep patterns. For instance, sleep difficulty followed by excessive sleepiness or vice versa is a symptom of sleep. Similarly, hyperactivity, impulsivity, restlessness, aggression, and agitation are behavioural symptoms of the condition. The treatments are life-long and include medications, therapies or supportive care, support groups, or family therapy are some of the effective forms of treatment globally. Bipolar I disorder, bipolar II disorder and cyclothymic disorder are some types of disorders defined in medicine. Bipolar disorder can severely affect an individual's life by impacting their energy levels, sleep patterns, moods, emotions and thoughts. It is vital to increase awareness about the condition and provide affordable & accessible care to these patients.

Get an overview of this study by requesting a free sample

Recent Development

November 2022 - Bukwang Pharmaceutical - Lurasidone, a brand-new medication for schizophrenia and bipolar disorder produced by Japan's Sumitomo Pharmaceutical, has recently been submitted for local marketing permission by Bukwang Pharmaceutical. The development comes after Bukwang's 2017 agreement with Sumitomo to get the rights to the drug's development and distribution. Compared to other atypical antipsychotics, lurasidone has fewer metabolic side effects. This gives it an edge in helping patients' social lives and quality of life. Additionally, it is an atypical antipsychotic medication used to treat bipolar depression, a condition for which few available treatments exist.

April 2022 - The FDA authorized IGALMI (dexmedetomidine) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II illness in adults, according to a statement released by BioXcel Therapeutics, Inc.

Market Dynamics:

Drivers:

The increasing prevalence of bipolar disorder – The exact cause that leads to an individual developing bipolar disorder is unknown. Research studies and surveys over the years have concluded that bipolar disorder can develop in response to environmental triggers. It is believed that children are born with a vulnerability that they might develop bipolar disorder. However, they may not develop it altogether. When and how they might or might not develop the condition would significantly depend on their genetics and surrounding environment. For instance, stressful events like the death of a loved one, substance abuse, or trauma may trigger the condition. Several organizations have reported an increase in the diagnosis of bipolar disorder in young individuals. The exact reasons for such a dramatic patient count increase are unknown. It is attributed to increasing awareness about the condition and providing affordable and accessible diagnostic and supportive care to the patients. The awareness regarding the condition also aims at destigmatizing the several stereotypes associated with the disease that dampen the confidence of individuals to ask for help. The government initiatives to develop an informed and sensitive society are increasing the out-patient count of seeking help. Scientific breakthroughs or medical research have expanded the scope of medicine to cover new aspects of the conditions by defining them under several categories. The increasing ambit of medicine to cover all aspects of the conditions leads to an increase in diagnosis, thus driving the global bipolar disorder market.

Restraints:

Side-effects of bipolar disorder medications are concerning – Bipolar disorder medications are powerful drugs aimed at stabilizing the patient's moods. The intended target of the drugs is to regulate the emotional highs and lows of the patients. However, the drugs have multiple side effects. The side effects can be nausea, tremors, headaches, muscle fatigue, hair loss, decreased sexual interest and loss of appetite. Some severe side effects of these drugs can be kidney or liver damage. While treating one condition, the drugs lead to several other negative developments that are equally taxing on the body, both mentally and physically. Therefore, the scope and severity of the side effects of bipolar disorder medications will hamper the growth of the market.

Opportunities:

Increase in medical research funding Bipolar disorder is a chronic condition with many unknowns. Extensive research and surveys are performed to understand any problem to address it comprehensively with policy interventions. Similarly, governments worldwide are increasing their funding towards bipolar disorder research to understand the condition and address it comprehensively like any other health condition. The increased funding has led to several scientific breakthroughs that have paved the way for developing better drugs, therapies and other medications that improve the lives of bipolar disorder patients. The increasing prevalence of bipolar disorder presents a vast consumer market of pharmaceutical giants. They have increased their research and development expenditure to develop bipolar disorder treatments like novel drugs and medical technology to exploit the growing market.

Challenges:

Misdiagnosis and no diagnosis of the condition – The social stigma associated with bipolar disorder discourage several individuals from seeking medical help. The lack of awareness about mental conditions like bipolar disorder in low- and middle-income countries leaves thousands of needy patients without supportive care. The social stigma leads no thousands of cases going unreported. Furthermore, the ambiguous difference between bipolar disorder and depression leads to the bipolar disorder being misdiagnosed as depression. The misdiagnoses lead to an entirely different treatment plan which fails to address the actual condition. Therefore, low to no reporting of bipolar disorder and misdiagnosis of the conditions will impede the growth of the global market.

Segmentation analysis:

Regional segmentation analysis:

The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the largest market for the global bipolar disorder market, with a 48.91% market revenue share in 2022. The increasing prevalence of the bipolar disorder in the region will drive the market. The increasing prevalence and incidence of bipolar disorder patients in the region can be attributed to two major factors. Firstly, the increasing incidence of bipolar disorder is primarily seen in young adults, given the lifestyle changes. The lifestyle changes include increased working hours, stressful life, no work-life balance, substance abuse and other mentally taxing personal relationships. The second reason relates to the increasing prevalence of the bipolar disorder, which can be attributed to the robust healthcare infrastructure with an advanced reporting structure. The government awareness campaigns have contributed to the de-stigmatization of the conditions and encouraged patients to seek help, thereby increasing the reporting of the condition. The advanced data collection mechanism and framework also contribute to increased diagnosis of the conditions in the region. Significant market players offering several medications and a well-established healthcare infrastructure will propel the market's growth.

North America region Bipolar Disorder Market Share in 2022 - 48.91%

 

www.thebrainyinsights.com

Check the geographical analysis of this market by requesting a free sample

Drugs class segment analysis

The drug class segment is divided into mood stabilizers, antipsychotic drugs, antianxiety drugs, anticonvulsants, antidepressant drugs and others. The antipsychotic drugs segment dominated the market with a revenue share of around 36% in 2022. Antipsychotic drugs are a class of neuroleptics. These drugs are considered the first line of treatment when handling a manic episode in a bipolar disorder patient. They can be administered with other drugs, such as mood stabilizers, which offer flexibility to physicians. They can be administered in the form of tablets or pills or can be injected as well. Innovations have led to olfactory antipsychotic drugs, which are inhaled. They are highly effective in controlling delusions, paranoia or hallucinations. Antipsychotic drugs control symptoms like incoherent speech, muddled thinking or violent behaviour. 

Mechanism of action analysis

The mechanism of action segment is divided into selective serotonin reuptake inhibitors, tricyclic antidepressants, benzodiazepines, serotonin-norepinephrine reuptake inhibitors, monoamine oxidase, beta blockers and others. The selective serotonin reuptake inhibitors segment dominated the market with a market share of around 37% in 2022. Selective serotonin reuptake inhibitors are a class of antidepressant drugs. They are primarily used to treat episodes of depression, anxiety, and other associated symptoms of a low emotional phase in a bipolar disorder patient. They are not addictive, which is a positive factor for the medication. The selective serotonin reuptake inhibitors also have fewer side effects, and visible effects are seen in two to three weeks. Several selective serotonin reuptake inhibitors include Cipramil, Oxactin, Seroxat, Lustral, Prozac and Priligy. They can be administered in combination with other drugs. Selective serotonin reuptake inhibitors are prescribed in several psychotherapy treatments as well.

Some of the Key Market Players:

  • AbbVie Inc.
  • Allergen Plc
  • AstraZeneca
  • Eli Lilly
  • GlaxoSmithKline
  • Janssen Pharmaceuticals
  • Johnson & Johnson Company
  • Novartis AG
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.

Report Description: 

Attribute Description
Market Size Revenue (USD Billion), Volume (Kg)
Market size value in 2022 USD 5.11 Billion
Market size value in 2030 USD 6.05 Billion
CAGR (2022 to 2030) 2.15%
Historical data 2019-2020
Base Year 2021
Forecast 2022-2030
Segments The research segment is based on drug class and mechanism of action.
Regional Segments The regions examined for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa.

Frequesntly Asked Questions

As per The Brainy Insights, the size of the bipolar disorder market was valued at USD 5.11 billion in 2022 to USD 6.05 billion by 2030.

The global bipolar disorder market is growing at a CAGR of 2.15% during the forecast period 2022-2030.

The North American region emerged as the largest market for the bipolar disorder.

The increasing bipolar disorder population will influence the market's growth.

1. Introduction
    1.1. Objectives of the Study
    1.2. Market Definition
    1.3. Research Scope
    1.4. Currency
    1.5. Key Target Audience

2. Research Methodology and Assumptions

3. Executive Summary

4. Premium Insights
    4.1. Porter’s Five Forces Analysis
    4.2. Value Chain Analysis
    4.3. Top Investment Pockets
          4.3.1. Market Attractiveness Analysis by Drug Class
          4.3.2. Market Attractiveness Analysis by Mechanism of Action
          4.3.3. Market Attractiveness Analysis by Region
    4.4. Industry Trends

5. Market Dynamics
    5.1. Market Evaluation
    5.2. Drivers
          5.2.1. The increasing bipolar disorder population
    5.3. Restraints
          5.3.1. Undesirable effects of bipolar disorder drugs
    5.4. Opportunities
          5.4.1. Increasing research and development expenditure
    5.5. Challenges
          5.5.1. Patent expiry on generic drugs developed by market players

6. Global Bipolar Disorder Market Analysis and Forecast, By Drug Class
    6.1. Segment Overview
    6.2. Mood Stabilizers
    6.3. Antipsychotic Drugs
    6.4. Antianxiety Drugs
    6.5. Anticonvulsants
    6.6. Antidepressant Drugs
    6.7. Others

7. Global Bipolar Disorder Market Analysis and Forecast, By Mechanism of Action
    7.1. Segment Overview
    7.2. Selective Serotonin Reuptake Inhibitors
    7.3. Tricyclic Antidepressants
    7.4. Benzodiazepines
    7.5. Serotonin Norepinephrine Reuptake Inhibitors
    7.6. Monoamine Oxidase
    7.7. Beta Blockers
    7.8. Others

8. Global Bipolar Disorder Market Analysis and Forecast, By Regional Analysis
    8.1. Segment Overview
    8.2. North America
          8.2.1. U.S.
          8.2.2. Canada
          8.2.3. Mexico
    8.3. Europe
          8.3.1. Germany
          8.3.2. France
          8.3.3. U.K.
          8.3.4. Italy
          8.3.5. Spain
    8.4. Asia-Pacific
          8.4.1. Japan
          8.4.2. China
          8.4.3. India
    8.5. South America
          8.5.1. Brazil
    8.6. Middle East and Africa
          8.6.1. UAE
          8.6.2. South Africa

9. Global Bipolar Disorder Market-Competitive Landscape
    9.1. Overview
    9.2. Market Share of Key Players in the Bipolar Disorder Market
          9.2.1. Global Company Market Share
          9.2.2. North America Company Market Share
          9.2.3. Europe Company Market Share
          9.2.4. APAC Company Market Share
    9.3. Competitive Situations and Trends
          9.3.1. Product Launches and Developments
          9.3.2. Partnerships, Collaborations, and Agreements
          9.3.3. Mergers & Acquisitions
          9.3.4. Expansions

10. Company Profiles
    10.1. AbbVie Inc.
          10.1.1. Business Overview
          10.1.2. Company Snapshot
          10.1.3. Company Market Share Analysis
          10.1.4. Company Product Portfolio
          10.1.5. Recent Developments
          10.1.6. SWOT Analysis
    10.2. Allergen Plc
          10.2.1. Business Overview
          10.2.2. Company Snapshot
          10.2.3. Company Market Share Analysis
          10.2.4. Company Product Portfolio
          10.2.5. Recent Developments
          10.2.6. SWOT Analysis
    10.3. AstraZeneca
          10.3.1. Business Overview
          10.3.2. Company Snapshot
          10.3.3. Company Market Share Analysis
          10.3.4. Company Product Portfolio
          10.3.5. Recent Developments
          10.3.6. SWOT Analysis
    10.4. Eli Lilly
          10.4.1. Business Overview
          10.4.2. Company Snapshot
          10.4.3. Company Market Share Analysis
          10.4.4. Company Product Portfolio
          10.4.5. Recent Developments
          10.4.6. SWOT Analysis
    10.5. GlaxoSmithKline
          10.5.1. Business Overview
          10.5.2. Company Snapshot
          10.5.3. Company Market Share Analysis
          10.5.4. Company Product Portfolio
          10.5.5. Recent Developments
          10.5.6. SWOT Analysis
    10.6. Janssen Pharmaceuticals
          10.6.1. Business Overview
          10.6.2. Company Snapshot
          10.6.3. Company Market Share Analysis
          10.6.4. Company Product Portfolio
          10.6.5. Recent Developments
          10.6.6. SWOT Analysis
    10.7. Johnson & Johnson Company
          10.7.1. Business Overview
          10.7.2. Company Snapshot
          10.7.3. Company Market Share Analysis
          10.7.4. Company Product Portfolio
          10.7.5. Recent Developments
          10.7.6. SWOT Analysis
    10.8. Novartis AG
          10.8.1. Business Overview
          10.8.2. Company Snapshot
          10.8.3. Company Market Share Analysis
          10.8.4. Company Product Portfolio
          10.8.5. Recent Developments
          10.8.6. SWOT Analysis
    10.9. Otsuka Holdings Co. Ltd.
          10.9.1. Business Overview
          10.9.2. Company Snapshot
          10.9.3. Company Market Share Analysis
          10.9.4. Company Product Portfolio
          10.9.5. Recent Developments
          10.9.6. SWOT Analysis
    10.10. Pfizer Inc.
          10.10.1. Business Overview
          10.10.2. Company Snapshot
          10.10.3. Company Market Share Analysis
          10.10.4. Company Product Portfolio
          10.10.5. Recent Developments
          10.10.6. SWOT Analysis
 

List of Table

1. Global Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

2. Global Mood Stabilizers Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

3. Global Antipsychotic Drugs Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

4. Global Antianxiety Drugs Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

5. Global Anticonvulsants Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

6. Global Antidepressant Drugs Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

7. Global Others Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

8. Global Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

9. Global Selective Serotonin Reuptake Inhibitors Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

10. Global Tricyclic Antidepressants Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

11. Global Benzodiazepines Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

12. Global Serotonin Norepinephrine Reuptake Inhibitors Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

13. Global Monoamine Oxidase Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

14. Global Beta Blockers Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

15. Global Others Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

16. Global Bipolar Disorder Market, By Region, 2019-2030 (USD Billion) 

17. North America Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

18. North America Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

19. U.S. Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

20. U.S. Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

21. Canada Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

22. Canada Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

23. Mexico Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

24. Mexico Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

25. Europe Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

26. Europe Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

27. Germany Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

28. Germany Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

29. France Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

30. France Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

31. U.K. Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

32. U.K. Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

33. Italy Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

34. Italy Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

35. Spain Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

36. Spain Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

37. Asia Pacific Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

38. Asia Pacific Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

39. Japan Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

40. Japan Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

41. China Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

42. China Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

43. India Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

44. India Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

45. South America Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

46. South America Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

47. Brazil Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

48. Brazil Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

49. Middle East and Africa Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

50. Middle East and Africa Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

51. UAE Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

52. UAE Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

53. South Africa Bipolar Disorder Market, By Drug Class, 2019-2030 (USD Billion) 

54. South Africa Bipolar Disorder Market, By Mechanism of Action, 2019-2030 (USD Billion) 

List of Figures 

1. Global Bipolar Disorder Market Segmentation

2. Bipolar Disorder Market: Research Methodology

3. Market Size Estimation Methodology: Bottom-Up Approach

4. Market Size Estimation Methodology: Top-Down Approach

5. Data Triangulation

6. Porter’s Five Forces Analysis 

7. Value Chain Analysis 

8. Global Bipolar Disorder Market Attractiveness Analysis By Drug Class

9. Global Bipolar Disorder Market Attractiveness Analysis By Mechanism of Action

10. Global Bipolar Disorder Market Attractiveness Analysis by Region

11. Global Bipolar Disorder Market: Dynamics

12. Global Bipolar Disorder Market Share By Drug Class (2022 & 2030)

13. Global Bipolar Disorder Market Share By Mechanism of Action (2022 & 2030)

14. Global Bipolar Disorder Market Share by Regions (2022 & 2030)

15. Global Bipolar Disorder Market Share by Company (2021)

This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global bipolar disorder market based on below-mentioned segments:

Global Bipolar Disorder Market by Drug Class:

  • Mood Stabilizers
  • Antipsychotic Drugs
  • Antianxiety Drugs
  • Anticonvulsants
  • Antidepressant Drugs
  • Others

Global Bipolar Disorder Market by Mechanism of Action:

  • Selective Serotonin Reuptake Inhibitors
  • Tricyclic Antidepressants
  • Benzodiazepines
  • Serotonin Norepinephrine Reuptake Inhibitors
  • Monoamine Oxidase
  • Beta Blockers
  • Others

Global Bipolar Disorder Market by Region:

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
  • Asia-Pacific
    • Japan
    • China
    • India
  • South America
    • Brazil
  • Middle East and Africa  
    • UAE
    • South Africa

Methodology

Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision. 

Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.

The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.

Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:

MARKET RESEARCH PROCESS

Data Procurement:

The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.

The data procurement stage involves in data gathering and collecting through various data sources.

This stage involves in extensive research. These data sources includes:

Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:

  • The organizational databases such as D&B Hoovers, and Bloomberg that helps us to identify the competitive scenario of the key market players/organizations along with the financial information.
  • Industry/Market databases such as Statista, and Factiva provides market/industry insights and deduce certain formulations. 
  • We also have contractual agreements with various reputed data providers and third party vendors who provide information which are not limited to:
    • Import & Export Data
    • Business Trade Information
    • Usage rates of a particular product/service on certain demographics mainly focusing on the unmet prerequisites

Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.

Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.

The supply side for a domain specific market is analysed by:

  • Estimating and projecting penetration rates through analysing product attributes, availability of internal and external substitutes, followed by pricing analysis of the product.
  • Experiential assessment of year-on-year sales of the product by conducting interviews.

The demand side for the market is estimated through:

  • Evaluating the penetration level and usage rates of the product.
  • Referring to the historical data to determine the growth rate and evaluate the industry trends

In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.

Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:

  • Applying demographic along with psychographic segmentation for market evaluation
  • Determining the Micro and Macro-economic indicators for each region 
  • Examining the industry indicators prevailing in the market. 

Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:

  • Data Screening: Data screening is the process of scrutinising data/information collected from primary research for errors and amending those collected data before data integration method. The screening involves in examining raw data, identifying errors and dealing with missing data. The purpose of the data screening is to ensure data is correctly entered or not. The Brainy Insights employs objective and systematic data screening grades involving repeated cycles of quality checks, screening and suspect analysis.
  • Data Integration: Integrating multiple data streams is necessary to produce research studies that provide in-depth picture to the clients. These data streams come from multiple research studies and our in house database. After screening of the data, our analysts conduct creative integration of data sets, optimizing connections between integrated surveys and syndicated data sources. There are mainly 2 research approaches that we follow in order to integrate our data; top down approach and bottom up approach.

Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.

This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.

Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.

The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:

  • CXOs and VPs of leading companies’ specific to sector
  • Purchasing managers, technical personnel, end-users
  • Key opinion leaders such as investment bankers, and industry consultants

Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.

Some Facts About The Brainy Insights

50%

Free Customization

300+

Fortune 500 Clients

1

Free Yearly Update On Purchase Of Multi/Corporate License

900+

Companies Served Till Date